0000899243-20-014517.txt : 20200529 0000899243-20-014517.hdr.sgml : 20200529 20200529143240 ACCESSION NUMBER: 0000899243-20-014517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200528 FILED AS OF DATE: 20200529 DATE AS OF CHANGE: 20200529 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Truitt Joseph CENTRAL INDEX KEY: 0001452429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19879 FILM NUMBER: 20926832 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC. STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-28 0 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001452429 Truitt Joseph C/O BIOSPECIFICS TECHNOLOGIES CORP. 2 RIGHTER PKWY, DELAWARE CORP. CENTER II WILMINGTON DE 19803 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 63.72 2020-05-28 4 A 0 130000 0.00 A 2030-05-28 Common Stock 130000 130000 D The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. The stock options vest in four equal installments over the four-year period following the date of grant. /s/ Joseph E. Truitt by Carl A. Valenstein, attorney- in-fact 2020-05-29